This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

KV Pharma, Silverleaf: Small-Cap Winners

NEW YORK ( TheStreet) -- Shares of specialty pharma company KV Pharmaceutical (KV-A) were zooming over 150% to $3.85 after U.S. regulators approved its drug, Makena, used to reduce the risk of preterm birth in women with a history of going into labor earlier than 37 weeks. Over 11 million shares were changing hands in afternoon trading.

Shares of timeshare operator Silverleaf (SVLF) soared 70% to $2.44 after hedge fund Cerberus Capital said it would buy the company for $94 million, a 75% premium to its previous day's closing price.

Fremont, California-based Opnext (OPXT) saw its share spurt 30% to $2.62 after it said its losses narrowed in the fiscal third quarter and issued an upbeat forecast for the fourth quarter.

Shares of Orexigen Therapeutics (OREX - Get Report) were once again attracting buying interest. The stock crashed over 70% earlier this week after regulators rejected its obesity drug. But shares were climbing 17% on Friday to $3.46.

China MediaExpress (CCME) denied a short-seller's allegations of fraud late Thursday. Muddy Waters Research, which has a short position in the stock, had accused the company of engaging in a massive pump and dump scheme. Shares were surging Friday by nearly 20% to $13.50 after plunging by 33% on Thursday.

Shares of Silicon Image (SIMG) jumped 15% to $8.87 after its results and first quarter forecasts beat estimates.

Shares of Evergreen Energy (EEE), Cirrus Logic (CRUS) and video services provider Harmonic (HLIT) were also prominent gainers in the small-cap sector on Friday trading.

-- Written by Shanthi Bharatwaj in New York

>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to

>To submit a news tip, send an email to:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
OREX $7.36 -1.08%
SIMG $7.28 0.00%
AAPL $130.28 0.47%
FB $81.53 -1.07%
GOOG $565.06 3.30%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs